Seminars in Hematology
Volume 43 , Pages S11-S17 , July 2006

Recent Advances in the Treatment of Childhood Immune Thrombocytopenic Purpura

  • Michael Tarantino

      Affiliations

    • M.T. is supported by Baxter and Amgen and serves as a Consultant to Baxter.
    • Corresponding Author InformationAddress correspondence to Michael Tarantino, MD, Comprehensive Bleeding Disorders Center, University of Illinois, 5019 N Executive Dr, Peoria, IL 61614.

References 

  1. Chun NS , Savani B , Seder RH , Taplin ME . Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura . Am J Hematol . 2003;74:276–279
  2. Tarantino MD , Young G , Bertolone SJ , Shafer FE , Kulkarni R , Kalinyak K , et al.   High-dose anti-D immune globulin is as effective as IVIg in the treatment of newly diagnosed immune thrombocytopenic purpura (ITP) in children . Blood . 2003;102(suppl 1):299a–300a
  3. Beardsley DS , Nathan DG . Platelet abnormalities in infancy and childhood . In:  Nathan DG ,  Orkin SH editor. Hematology of Infancy and Childhood . (ed 5). Philadelphia, PA: Saunders; 1988;p. 1585–1630
  4. Farrington P , Pugh S , Colville A , Flower A , Nash J , Morgan-Capner P , et al.   A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines . Lancet . 1995;345:567–569
  5. George JN , Woolf SH , Raskob GE , Wasser JS , Aledort LM , Ballem PJ , et al.   Idiopathic thrombocytopenic purpura (A practice guideline developed by explicit methods for the American Society of Hematology) . Blood . 1996;88:3–40
  6. Cines DB , Blanchette V . Immune thrombocytopenic purpura . N Engl J Med . 2002;346:995–1008
  7. Calpin C , Dick P , Poon A , Feldman W . Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia? . Arch Pediatr Adolesc Med . 1998;152:345–347
  8. Warner MN , Moore JC , Warkentin TE , Santos AV , Kelton JG . A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura . Br J Haematol . 1999;104:442–447
  9. Bellucci S , Charpak Y , Chastang C , Tobelem G . Low doses v conventional doses of corticoids in immune thrombocytopenic purpura (ITP) (Results of a randomized clinical trial in 160 children, 223 adults) . Blood . 1988;71:1165–1169
  10. Buchanan GR , Holtkamp CA . Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial . Am J Pediatr Hematol Oncol . 1984;6:355–361
  11. Sartorius JA . Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study . Am J Pediatr Hematol Oncol . 1984;6:165–169
  12. Blanchette VS , Luke B , Andrew M , Sommerville-Nielsen S , Barnard D , de Veber B , et al.   A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura . J Pediatr . 1993;123:989–995
  13. Blanchette V , Imbach P , Andrew M , Adams M , McMillan J , Wang E , et al.   Randomised trial of intravenous immune globulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura . Lancet . 1994;344:703–707
  14. Carcao MD , Zipursky A , Butchart S , Leaker M , Blanchette VS . Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP) . Acta Pediatr . 1998;424(suppl):71–74
  15. Albayrak D , Islek I , Kalayci AG , Gurses N . Acute immune thrombocytopenic purpura (A comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin) . J Pediatr . 1994;125:1004–1007
  16. Ancona KG , Parker RI , Atlas MP , Prakash D . Randomized trial of high-dose methylprednisolone versus intravenous immune globulin for the treatment of acute idiopathic thrombocytopenic purpura in children . J Pediatr Hematol Oncol . 2002;24:540–544
  17. van Hoff J , Ritchey K . Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura . J Pediatr . 1988;113:563–566
  18. Warrier I , Bussel JB , Valdez L , Barbosa J , Beardsley DS  Low-Dose IVIG Study Group . Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura . J Pediatr Hematol Oncol . 1997;19:197–201
  19. Benesch M , Kerbl R , Lackner H , Berghold A , Schwinger W , Triebl-Roth K , et al.   Low-dose versus high-dose immune globulin for primary treatment of acute immune thrombocytopenic purpura in children (Results of prospective, randomized single-center trial) . J Pediatr Hematol Oncol . 2003;25:797–800
  20. Scaradavou A , Woo B , Woloski BM , Cunningham-Rundles S , Ettinger LJ , Aledort LM , et al.   Intravenous anti-D treatment of immune thrombocytopenic purpura (Experience in 272 patients) . Blood . 1997;89:2689–2700
  21. Tarantino MD , Madden RM , Fennewald DL , Patel CC , Bertolone SJ . Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin . J Pediatr . 1999;134:21–26
  22. Monteleone PM , Vander Heyden MA , Steele DA , Kelleher JH . Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura (A pilot study) . Haematologica . 2000;85:887–888
  23. Newman GC , Novoa MV , Fodero EM , Lesser ML , Woloski BM , Bussel JB . A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura . Br J Haematol . 2001;112:1076–1078
  24. Tarantino MD , Buchanan GR . The pros and cons of drug therapy for immune thrombocytopenic purpura in children . Hematol Oncol Clin North Am . 2004;18:1301–1314
  25. Imbach P , Gaedicke G , Joller P . Interim evaluation of two cooperative studies assessing the effects of intravenous immunoglobulin (i.v. IgG) on childhood idiopathic thrombocytopenic purpura (ITP) (I. Randomized study comparing i.v. IgG with oral corticosteroids in previously untreated acute ITP. II. Prospective study of i.v. IgG in acute and chronic ITP unresponsive to previous treatment) . Blut . 1984;48:357–361
  26. Duru F , Fisgin T , Yarali N , Kara A . Clinical course of children with immune thrombocytopenic purpura treated with intravenous immune globulin G or megadose methylprednisolone or observed without therapy . Pediatr Hematol Oncol . 2002;19:219–225
  27. Beck CE , Nathan PC , Parkin PC , Blanchette VS , Macarthur C . Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children (A systematic review and meta-analysis of randomized controlled trials) . J Pediatr . 2005;147:521–527
  28. Butros LJ , Bussel JB . Intracranial hemorrhage in immune thrombocytopenic purpura (A retrospective analysis) . J Pediatr Hematol Oncol . 2003;25:660–664
  29. Adams JR , Nathan DP , Bennett CL . Pharmacoeconomics of therapy for ITP (Steroids, i.v.Ig, anti-D, and splenectomy) . Blood Rev . 2002;16:65–67
  30. Medeiros D , Buchanan GR . Major hemorrhage in children with idiopathic thrombocytopenic purpura (Immediate response to therapy and long-term outcome) . J Pediatr . 1998;133:334–339
  31. Dickerhoff R , von Ruecker A . The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immune globulins or sustained prednisone treatment . J Pediatr . 2000;137:629–632
  32. Kuhne T , Imbach P , Bolton-Maggs PH , Berchtold W , Blanchette V , Buchanan GR  Intercontinental Childhood ITP Study Group . Newly diagnosed idiopathic thrombocytopenic purpura in childhood (An observational study) . Lancet . 2001;358:2122–2125
  33. Centers for Disease Control and Prevention (CDC) . Renal insufficiency and failure associated with immune globulin intravenous therapy—United States, 1985-1998 . MMWR Morb Mortal Wkly Rep . 1999;48:518–521
  34. Schiavotto C , Ruggeri M , Rodeghiero F . Adverse reactions after high-dose intravenous immune globulin (Incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature) . Haematologica . 1993;78(suppl 2):35–40
  35. Zaidan R , Al Moallem M , Wani BA , Shameena AR , Al Tahan AR , Daif AK , et al.   Thrombosis complicating high dose intravenous immune globulin (Report of three cases and review of the literature) . Eur J Neurol . 2003;10:367–372
  36. Gottlieb S . Intravenous immune globulin increases risk of thrombotic events . BMJ . 2002;324:1056
  37. Gaines AR . Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients . Blood . 2000;95:2523–2529
  38. Gaines AR . Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura . Blood . 2005;106:1532–1537
  39. Roberti I , Bagtas JF , Reisman L , Murphy S . Severe acute renal failure due to hemoglobinuria after use of WinRho for the treatment of idiopathic thrombocytopenic purpura . Clin Pediatr (Phila) . 2001;40:61–62
  40. Kees-Folts D , Abt AB , Domen RE , Freiberg AS . Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura . Pediatr Nephrol . 2002;17:91–96
  41. Levendoglu-Tugal O , Jayabose S . Intravenous anti-D immune globulin-induced intravascular hemolysis in Epstein-Barr virus-related thrombocytopenia . J Pediatr Hematol Oncol . 2001;23:460–463
  42. British Committee for Standards in Haematology and General Haematology Task Force . Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy . Br J Haematol . 2003;120:574–596
  43. Sutor AH , Dickerhoff R , Gaedicke G , et al.   Hämostasiologie (akute postinffektiöse immunthrombozytopenie im kindesalter) . In:  Reinhard D ,  Cruetzig U ,  Kiess W ,  Luthardt T ,  Michalk D ,  Schmidt E , et al. editor. Leitlinien Kenderheilkunde und Jugenmedizin . Munich, Germany: Urban & Fischer; 1999;p. 23–27
  44. Erduran E , Aslan Y , Gedik Y , Orhan F . A randomized and comparative study of intravenous immune globulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura . Turk J Pediatr . 2003;45:295–300
  45. Foster CB , Zhu S , Erichsen HC , Lehrnbecher T , Hart ES , Choi E , et al.   Early Chronic ITP Study Group: Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: A pilot study . Br J Haematol . 2001;113:596–599
  46. Bruin M , Bierings M , Uiterwaal C , Revesz T , Bode L , Wiesman ME , et al.   Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood (Results of a prospective study) . Br J Haematol . 2004;127:561–567
  47. Carcao MD , Blanchette VS , Wakefield CD , Stephens D , Ellis J , Matheson K , et al.   Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura . Br J Haematol . 2003;120:135–141
  48. Tarantino MD , Williams SA , Weber LC , Nugent DJ . FCGR3A genotype affects the platelet response to immune globulin (Ig) treatment of acute immune thrombocytopenic purpura (ITP) in children . 2005; Presented at the XXth Congress of the International Society on Thrombosis and Haemostasis, Sydney, Australia, August 6-12, (poster P2104)

PII: S0037-1963(06)00090-4

doi: 10.1053/j.seminhematol.2006.04.008

Seminars in Hematology
Volume 43 , Pages S11-S17 , July 2006

Article Tools

* Image Usage & Resolution